NCT00443924View on ClinicalTrials.gov

Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Ocular HypertensionOpen Angle Glaucoma
Interventions
DRUG

INS115644 Ophthalmic Solution

One drop of Concentration #1 in one eye and one drop of placebo in contralateral eye every 12 hours for three days

DRUG

Placebo

One drop of placebo in each eye every 12 hours for three days

DRUG

INS115644 Ophthalmic Solution

One drop of Concentration #2 in one eye and one drop of placebo in the contralateral eye every twelve hours for three days

DRUG

INS115644 Ophthalmic Solution

One drop of Concentration #3 in one eye and one drop of placebo in the contralateral eye every twelve hours for three days

DRUG

INS115644 Ophthalmic Solution

One drop of Concentration #4 in one eye and one drop of placebo in the contralateral eye every twelve hours for three days

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00443924 - Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma | Biotech Hunter | Biotech Hunter